Literature DB >> 16844318

Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.

Darko Kastelan1, Marija Kastelan, Lara Prpic Massari, Mirko Korsic.   

Abstract

Psoriasis is a chronic erythematosquamous disease affecting about 2-3% of the population. It is generally considered to be a T cell-mediated disorder. Psoriasis is characterized by Th1-type cytokine pattern with the predominant secretion of IL-2, IL-6, IFN-gamma and TNF-alpha. Such cytokine pattern is sufficient in inducing keratinocyte hyperproliferation, a hallmark of psoriasis. It seems that development of psoriatic lesions is mediated by TNF-alpha and proliferation of local T cells is dependent on local TNF-alpha production. IL-6 enhances activation, proliferation and chemotaxis of T cells into psoriatic lesions. It is also a direct keratinocyte mitogen that could directly stimulate keratinocyte proliferation. Data of possible association between psoriasis and reduced bone mineral density (BMD) are limited and therefore, not fully conclusive. The major limitation of two studies reported so far was small sample size. Based on increased concentrations of TNF-alpha and IL-6 in psoriasis we hypothesized that these patients are more prone to osteoporosis than healthy subjects. TNF-alpha enhances bone resorption via stimulating osteoclast development and activity as well as bone formation. On the other hand, IL-6 is also a potent stimulator of bone resorption. Moreover, increased production of TNF-alpha and IL-6 has been found in postmenopausal women with osteoporosis. Several lines of evidence support our hypothesis; higher value of IL-6 was recorded in children with idiopathic osteoporosis than in healthy controls; TNF-alpha knock-out mice do not lose bone after ovariectomy; polymorphism of TNFRSF1B gene which encodes 75 Kd TNF receptor is associated with BMD; treatment with anti-TNF-alpha antibody exert beneficial effect on bone metabolism in patients with rheumatoid arthritis and finally, raloxifene inhibit osteoclast activity by reducing TNF-alpha and IL-6 synthesis. However, our hypothesis raised number of questions. Are increased serum concentrations of TNF-alpha and IL-6 mirrored by increased concentrations of these cytokines on the local level? Furthermore, could other cytokines relevant in the pathogenesis of the psoriasis, first of all IFN-gamma, modulate the risk of osteoporosis? Thus, a large prospective, case-control study with the data on BMD, biochemical parameters of bone turnover and fractures have to be done to test our hypothesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844318     DOI: 10.1016/j.mehy.2006.04.069

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  13 in total

1.  Immune and inflammatory pathways are involved in inherent bone marrow ossification.

Authors:  Umut Atakan Gurkan; Ryan Golden; Vipuil Kishore; Catherine P Riley; Jiri Adamec; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

2.  Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan.

Authors:  J J Keller; J-H Kang; H-C Lin
Journal:  Osteoporos Int       Date:  2012-10-07       Impact factor: 4.507

Review 3.  Psoriasis and Systemic Inflammatory Disorders.

Authors:  Tomoko Tashiro; Yu Sawada
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

4.  Treatment with hydrogen molecule alleviates TNFα-induced cell injury in osteoblast.

Authors:  Wen-Wen Cai; Ming-Hua Zhang; Yong-Sheng Yu; Jin-Hua Cai
Journal:  Mol Cell Biochem       Date:  2012-12-01       Impact factor: 3.396

5.  Dye-doped silica nanoparticle labels/protein microarray for detection of protein biomarkers.

Authors:  Hong Wu; Qisheng Huo; Susan Varnum; Jun Wang; Guodong Liu; Zimin Nie; Jun Liu; Yuehe Lin
Journal:  Analyst       Date:  2008-07-28       Impact factor: 4.616

Review 6.  Molecular Aspects of Bone Resorption in β-Thalassemia Major.

Authors:  Najmaldin Saki; Saeid Abroun; Fatemeh Salari; Fakher Rahim; Mohammad Shahjahani; Mohammadi-Asl Javad
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

Review 7.  Psoriasis: classical and emerging comorbidities.

Authors:  Maria de Fátima Santos Paim de Oliveira; Bruno de Oliveira Rocha; Gleison Vieira Duarte
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

Review 8.  Psoriasis: new comorbidities.

Authors:  Jackson Machado-Pinto; Michelle dos Santos Diniz; Nádia Couto Bavoso
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

9.  Bone mineral density is lower in male than female patients with plaque-type psoriasis in Iran.

Authors:  V Lajevardi; R Abedini; M Moghaddasi; S F Nassiri; A Goodarzi
Journal:  Int J Womens Dermatol       Date:  2017-09-20

10.  Association of the TNF-α, IL-2, and IL-2RB gene variants with susceptibility to psoriasis in a Turkish cohort.

Authors:  Aslihan Gulel; Huseyin Serhat Inaloz; Ayse Feyda Nursal; Tugce Sever; Sacide Pehlivan
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.